openPR Logo
Press release

MEDIA ADVISORY 4/3 "It Starts with Sylvan" Donates $1,000 towards 2012 Walk to End Alzheimer's

04-05-2012 04:17 AM CET | Associations & Organizations

Press release from: Alzheimer's Association Long Island

/ PR Agency: PRMG
Who: Mary Ann Malack-Ragona, Executive Director/Chief Executive Officer, Alzheimer’s Association Long Island
Patty Gorman, Team Captain, It Starts With Sylvan

What: In support of the 2012 Walk to End Alzheimer’s, It Starts With Sylvan — a group of students at Sylvan Avenue Elementary School — will present Alzheimer’s Association Long Island with a check in the amount of $1,000 to benefit the Walk, which will take place on September 8 at Old Bethpage Village Restoration.

Students helped raise money during the month of March by purchasing AALI awareness ribbons for a donation. In addition, peer leaders sold Alzheimer’s awareness pens, shoelaces, backpack tags and bracelets to students at the school’s “Awareness Shop.” They also wrote letters to their “Grandpals” who reside at Atria Senior Living Facility.

There are 5.4 million people in the U.S. who are afflicted with Alzheimer’s. Of that number, 60,000 live here on Long Island. In the coming years, the Association expects to see a drastic increase in these numbers if a cure is not found. Currently, one in eight people over the age of 65 have Alzheimer’s disease.

When: Tuesday, April 3

8:30 a.m.

Where: Sylvan Avenue Elementary School

600 Sylvan Avenue

Bayport, NY

Directions: From the LIE: Exit 62 toward Blue Point/Nicolls Road/Stony Brook: Take Nicolls Road (CR 97) towards Blue Point. Go half a mile, then turn right onto Purick Street. After 4.6 miles, turn left onto Sylvan Avenue. School will be on the right.

From Sunrise Highway (Route 27): Exit 51 toward Blue Point/Stony Brook/Nicolls Road. Take ramp onto Nicolls Rd (CR 97 S). After 0.7 mile, turn right onto Purick Street then make a left onto Sylvan Avenue. School will be on the right.

Photo Ops: Ms. Malack-Ragona accepting the check from Ms. Gorman and the It Starts With Sylvan team members.

About Alzheimer’s Association

The Alzheimer's Association is the world’s leading voluntary health organization in Alzheimer’s care, support and research. Our mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer’s. For more information, visit www.alz.org.

Hank Russell, Public Relations Director
The Public Relations and Marketing Group
156 North Ocean Avenue
Patchogue, NY 11772
(631) 207-1057
hrussell@theprmg.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release MEDIA ADVISORY 4/3 "It Starts with Sylvan" Donates $1,000 towards 2012 Walk to End Alzheimer's here

News-ID: 216684 • Views: 4419

More Releases from Alzheimer's Association Long Island

Alzheimer’s Association Long Island Hosts Second East End Walk to End Alzheime …
Following the success of this summer’s East End Walk to End Alzheimer’s in Riverhead, Alzheimer’s Association Long Island will have its second East End Walk to End Alzheimer’s/Fall Festival on October 20 at the intersection of Main Street and the Village Green (near the gazebo) in Westhampton Beach. Registration begins at 9 a.m., followed by the opening ceremony at 10 a.m. and the Walk at 11 a.m. The opening ceremony will
East End Walk to End Alzheimer’s to be Held August 25
Alzheimer’s Association Long Island is inviting Eastern Long Island residents to unite in a movement to reclaim the future for millions by participating in the East End Walk to End Alzheimer’s on August 25. This year’s walk will begin at Downtown Riverhead’s Grangebel Park on Peconic Avenue and end at the Long Island Aquarium & Exhibition Center (formerly known as Atlantis Marine World), located at 431 Main Street in Riverhead.
Alzheimer’s Association Long Island Welcomes New Care Consultant Amy Oster
Alzheimer’s Association Long Island has announced that Amy Oster will join the organization as its Care Consultant. In her new role, Ms. Oster will regularly meet with families of those suffering from Alzheimer’s disease to develop a long-term care plan and discuss available programs and resources. Ms. Oster has been successful in facilitating the support group for caregivers, which has greatly increased in size under her leadership. Before joining Alzheimer’s Association
Alzheimer’s Association Long Island Hosts Inaugural Physician’s Outreach Din …
On March 7, Alzheimer’s Association Long Island hosted 50 physicians at its first-ever Physician’s Outreach Dinner at the Melville Marriott. Guest speakers included Dr. Peter Davies, Ronda Wexler-Kahn and Mindy Wexler-Rosenfeld, Dr. Norman Pflaster and Ronald Fatoullah. Dr. Davies, Scientific Director, Litwin-Zucker Center for the Research of Alzheimer’s Disease and Memory Disorders, Feinstein Institute for Medical Research and North Shore LIJ Health Care System, covered treatments and diagnostic testing for the

All 5 Releases


More Releases for Alzheimer

Alzheimer Disease Drugs Market Global Trends, Market Share, Industry Size, Growt …
Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during the forecasting period. Alzheimer's treatment is a high risk, high reward market. Drugs currently
Anti-β-Alzheimer Therapies Market Analysis with Technological Advancement and G …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Alzheimer Diagnostic Tests Market GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as